Insider Buy/Sell Details for the Biotechnology Industry — June 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1261)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
762
Price
$549.55
Total Value
$418.76K
Shares Held After
46,762
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
645
Price
$548.77
Total Value
$353.96K
Shares Held After
47,524
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
441
Price
$547.87
Total Value
$241.61K
Shares Held After
48,169
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
301
Price
$546.38
Total Value
$164.46K
Shares Held After
48,610
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
418
Price
$545.08
Total Value
$227.84K
Shares Held After
48,911
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
684
Price
$543.54
Total Value
$371.78K
Shares Held After
49,329
% of Holdings
1.4%
INSMED Inc (INSM)
Lewis William — Director
Shares
1,292
Price
$106.27
Total Value
$137.30K
Shares Held After
258,917
% of Holdings
0.5%
INSMED Inc (INSM)
Lewis William — Director
Shares
2,456
Price
$105.27
Total Value
$258.54K
Shares Held After
260,209
% of Holdings
0.9%
INSMED Inc (INSM)
Lewis William — Director
Shares
3,723
Price
$104.28
Total Value
$388.23K
Shares Held After
262,665
% of Holdings
1.4%
INSMED Inc (INSM)
Lewis William — Director
Shares
1,836
Price
$103.10
Total Value
$189.29K
Shares Held After
266,388
% of Holdings
0.7%
INSMED Inc (INSM)
Lewis William — Director
Shares
12,091
Price
$102.34
Total Value
$1.24M
Shares Held After
268,224
% of Holdings
4.3%
Dyne Therapeutics, Inc. (DYN)
Lucera Erick — Chief Financial Officer
Shares
2,362
Price
$20.37
Total Value
$48.11K
Shares Held After
121,563
% of Holdings
1.9%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
5,019
Price
$21.10
Total Value
$105.90K
Shares Held After
1,081,044
% of Holdings
0.5%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
6,382
Price
$21.10
Total Value
$134.66K
Shares Held After
1,478,378
% of Holdings
0.4%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
12,699
Price
$21.10
Total Value
$267.95K
Shares Held After
4,742,410
% of Holdings
0.3%
Alpha Tau Medical Ltd. (DRTS)
Levy Raphi — Chief Financial Officer
Shares
15,778
Price
$11.00
Total Value
$173.56K
Shares Held After
110,180
% of Holdings
12.5%
Alpha Tau Medical Ltd. (DRTS)
Levy Raphi — Chief Financial Officer
Shares
4,222
Price
$11.00
Total Value
$46.44K
Shares Held After
125,958
% of Holdings
3.2%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
2,646
Price
$118.60
Total Value
$313.82K
Shares Held After
564,668
% of Holdings
0.5%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
3,359
Price
$117.50
Total Value
$394.68K
Shares Held After
567,314
% of Holdings
0.6%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
11,375
Price
$116.53
Total Value
$1.33M
Shares Held After
570,673
% of Holdings
2.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
8,389
Price
$115.57
Total Value
$969.52K
Shares Held After
582,048
% of Holdings
1.4%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,289
Price
$114.65
Total Value
$147.78K
Shares Held After
590,437
% of Holdings
0.2%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,437
Price
$113.70
Total Value
$163.39K
Shares Held After
591,726
% of Holdings
0.2%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
100
Price
$111.89
Total Value
$11.19K
Shares Held After
593,163
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
86
Price
$110.79
Total Value
$9.53K
Shares Held After
593,263
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
265
Price
$110.30
Total Value
$29.23K
Shares Held After
593,349
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
2,011
Price
$108.83
Total Value
$218.86K
Shares Held After
593,614
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
46
Price
$129.61
Total Value
$5.96K
Shares Held After
529,718
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
23
Price
$108.02
Total Value
$2.48K
Shares Held After
595,625
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
305
Price
$128.69
Total Value
$39.25K
Shares Held After
529,764
% of Holdings
0.1%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,399
Price
$107.30
Total Value
$150.11K
Shares Held After
595,648
% of Holdings
0.2%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
3,507
Price
$127.37
Total Value
$446.69K
Shares Held After
530,069
% of Holdings
0.7%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
19,089
Price
$118.60
Total Value
$2.26M
Shares Held After
3,113,085
% of Holdings
0.6%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
223
Price
$126.71
Total Value
$28.26K
Shares Held After
533,576
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
24,268
Price
$117.50
Total Value
$2.85M
Shares Held After
3,132,174
% of Holdings
0.8%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
522
Price
$125.82
Total Value
$65.68K
Shares Held After
533,799
% of Holdings
0.1%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
81,500
Price
$116.53
Total Value
$9.50M
Shares Held After
3,156,442
% of Holdings
2.5%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,639
Price
$124.61
Total Value
$204.24K
Shares Held After
534,321
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
58,205
Price
$115.57
Total Value
$6.73M
Shares Held After
3,237,942
% of Holdings
1.8%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,517
Price
$123.62
Total Value
$187.53K
Shares Held After
535,960
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
9,229
Price
$114.65
Total Value
$1.06M
Shares Held After
3,296,147
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
698
Price
$122.67
Total Value
$85.62K
Shares Held After
537,477
% of Holdings
0.1%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
10,215
Price
$113.70
Total Value
$1.16M
Shares Held After
3,305,376
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
5,689
Price
$121.38
Total Value
$690.53K
Shares Held After
538,175
% of Holdings
1.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
719
Price
$111.89
Total Value
$80.45K
Shares Held After
3,315,591
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
15,660
Price
$120.66
Total Value
$1.89M
Shares Held After
543,864
% of Holdings
2.8%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
614
Price
$110.79
Total Value
$68.03K
Shares Held After
3,316,310
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
5,144
Price
$119.71
Total Value
$615.79K
Shares Held After
559,524
% of Holdings
0.9%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,915
Price
$110.30
Total Value
$211.22K
Shares Held After
3,316,924
% of Holdings
0.1%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
337
Price
$129.61
Total Value
$43.68K
Shares Held After
2,862,351
% of Holdings
0.0%
Showing 51–100 of 1261 transactions (page 2 of 26)